Product NDC: | 0703-5051 |
Proprietary Name: | Desmopressin acetate |
Non Proprietary Name: | Desmopressin acetate |
Active Ingredient(s): | 4 ug/mL & nbsp; Desmopressin acetate |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0703-5051 |
Labeler Name: | Teva Parenteral Medicines, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA074888 |
Marketing Category: | ANDA |
Start Marketing Date: | 19971101 |
Package NDC: | 0703-5051-03 |
Package Description: | 10 VIAL in 1 TRAY (0703-5051-03) > 1 mL in 1 VIAL (0703-5051-01) |
NDC Code | 0703-5051-03 |
Proprietary Name | Desmopressin acetate |
Package Description | 10 VIAL in 1 TRAY (0703-5051-03) > 1 mL in 1 VIAL (0703-5051-01) |
Product NDC | 0703-5051 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Desmopressin acetate |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19971101 |
Marketing Category Name | ANDA |
Labeler Name | Teva Parenteral Medicines, Inc. |
Substance Name | DESMOPRESSIN ACETATE |
Strength Number | 4 |
Strength Unit | ug/mL |
Pharmaceutical Classes | Factor VIII Activator [EPC],Increased Coagulation Factor VIII Activity [PE],Increased Coagulation Factor VIII Concentration [PE],Vasopressin Analog [EPC],Vasopressins [Chemical/Ingredient] |